丁燕,吴晓玲,林梅,谢奕丹,周敏华
DING Yan,WU Xiaoling,LIN Mei,XIE Yidan,ZHOU Minhua

• 1:广州中医药大学附属广东中西医结合医院
• 2:广东省中西医结合医院药学部

摘要(Abstract)：

目的系统评价兰索拉唑与其它质子泵抑制剂治疗胃食管反流病(GERD)的临床疗效,为临床用药提供参考。方法计算机检索中国期刊全文数据库(CNKI)、万方、维普、Pub Med、Medline、Cochrane Library数据库,收集国内外已公开发表的比较兰索拉唑和其它质子泵抑制剂治疗胃食管反流病疗效的随机对照试验(RCT),以临床症状缓解率和内镜下治愈率为评价指标,采用Cochrane协作网提供的Meta分析软件Rev Man5.0进行数据的处理与分析。结果最终共纳入中文RCT 13篇,英文RCT 6篇,合计9143例患者,Meta分析结果显示:兰索拉唑与奥美拉唑[OR=0.71,95%CI(0.33,1.54),P>0.05]、雷贝拉唑[OR=0.59,95%CI(0.26,1.37),P>0.05]临床症状缓解率相当,但不及埃索美拉唑[OR=0.38,95%CI(0.24,0.62),P<0.05],仅一篇文献比较了与泮托拉唑临床症状缓解率,结果无统计学差异;兰索拉唑与奥美拉唑[OR=1.08,95%CI(0.86,1.35),P>0.05]、泮托拉唑[OR=0.72,95%CI(0.44,1.16),P>0.05]内镜下治愈率相当,但不及雷贝拉唑[OR=0.44,95%CI(0.22,0.85),P<0.05]、埃索美拉唑[OR=0.48,95%CI(0.33,0.70),P<0.05]。结论在治疗胃食管反流病时,兰索拉唑与奥美拉唑、泮托拉唑疗效相当,不及埃索美拉唑、雷贝拉唑,但该结论仍需大规模多中心研究进一步证实。
OBJECTIVE To systematically evaluate the therapeutic efficacy of lansoprazole vs other proton pump inhibitors in the treatment of gastroesophageal refluxdisease( GERD),so as to provide reference for its clinical medication. METHODS The randomized controlled trials( RCT) that compare the efficacy of lansoprazole and other proton pump inhibitors in the treatment of GERD were collected from CNKI,Wanfang,VIP,Pub Med,Medline,Cochrane Library. The clinical symptom remission rate and endoscopic cure rate were used as the evaluation index,and meta-analysis software Rev Man5. 0 in Cochrane Collaboration was used to do the data processing and analysis. RESULTS A total of 13 Chinese RCT and 6 English RCT were included,involving 9 143 patients. Results of Meta-analysis showed that: there were no difference in the clinical symptom remission rate between lansoprazole,omeprazole [OR = 0. 71,95% CI( 0.33,1. 54),P > 0. 05],and rabeprazole [OR = 0. 59,95% CI( 0. 26,1. 37),P > 0. 05],but lansoprazole not as good as esomeprazole[OR =0. 38,95% CI( 0. 24,0. 62),P < 0. 05],only one RCT compared with pantoprazole,no difference between the results. There were no difference in the endoscopic cure rate between lansoprazole,omeprazole [OR = 1. 08,95% CI( 0. 86,1. 35),P > 0. 05 ],pantoprazole [OR = 0. 72,95% CI( 0. 44,1. 16),P > 0. 05],but lansoprazole not as good as rabeprazole [OR = 0. 44,95% CI( 0. 22,0.85),P < 0. 05],esomeprazole [OR = 0. 48,95% CI( 0. 33,0. 70),P < 0. 05]. CONCLUSION In the treatment of GERD,there were no difference in the therapeutic efficacy between lansoprazole,omeprazole and pantoprazole,but lansoprazole not as good as esomeprazole,rabeprazole. Large scale,multiple center studies are required to validate those conclusions.

关键词(KeyWords)： 质子泵抑制剂;胃食管反流病;Meta分析
proton pump inhibitor(PPI);gastroesophageal reflux disease(GERD);Meta-analysis

Abstract:

Keywords:

基金项目(Foundation): 国家科技支撑计划子课题(2013BAI06B04Y023062);; 佛山市科技发展专项资金项目(2012AA100662)

作者(Author): 丁燕,吴晓玲,林梅,谢奕丹,周敏华
DING Yan,WU Xiaoling,LIN Mei,XIE Yidan,ZHOU Minhua

参考文献(References)：

• [1]刘诗.改变生活方式在治疗胃食管反流病的作用[J].临床消化病杂志,2008,20(1):8-9.
• [2]吴学红,翟穗燕,张国芬.兰索拉唑治疗反流性食管炎临床疗效观察[J].广西医学,2006,28(5):689-690.
• [3]徐欣萍,杨昭徐.4种质子泵抑制剂治疗胃食管反流病的临床观察[J].中国新药杂志,2008,17(1):73-74.
• [4]杨勇.3种质子泵抑制剂治疗反流性胃炎的疗效分析[J].现代预防医学,2010,37(7):1379-1380.
• [5]蒋琦,章四杰,谢双林,等.5种抑酸药治疗反流性食管炎的临床疗效与药物经济学分析[J].现代实用医学,2011,23(4):421-423.
• [6]张美玲.3种质子泵抑制剂治疗反流性食管炎的成本-效果分析[J].中国药业,2005,14(6):59-60.
• [7]刘伟浩,钟永基.质子泵抑制剂联合莫沙必利治疗反流性食管炎的疗效比较[J].中国社区医师(医学专业),2010,12(27):34-35.
• [8]徐存美,王秀莲,栗鹏.埃索美拉唑与兰索拉唑治疗糜烂性食管炎疗效比较[J].中国中医药咨讯,2011,3(13):381.
• [9]曹艳菊,陈琰.埃索美拉唑治疗反流性食管炎的疗效观察[J].胃肠病学和肝病学杂志,2007,16(3):208+212.
• [10]杨应雄,任权,向军英,等.埃索美拉唑联合伊托必利治疗反流性食管炎的疗效观察[J].川北医学院学报,2010,25(4):326-327.
• [11]马晓鹂,周宇,魏国丽.埃索美拉唑与兰索拉唑治疗反流性食管炎的疗效比较[J].中国药房,2009,20(35):2764-2766.
• [12]李新荣,陈世霞.埃索美拉唑联合莫沙必利治疗反流性食管炎的临床疗效分析[J].中国医药指南,2012,10(10):520-522.
• [13]赵敬东.兰索拉唑治疗胃食管反流病的疗效观察[J].中国药师,2006,9(7):650-651.
• [14]郑日男.奥美拉唑、泮托拉唑、兰索拉唑和埃索美拉唑对反流性食管炎患者症状缓解的比较研究[J].胃肠病学和肝病学杂志,2009,18(7):642-645.
• [15]Castell DO,Richter JE,Robinson M.Efficacy and Safety of Lansoprazole in the Treatment of Erosive Refiux Esophagitis[J].Am J Gastroenterol,1996,91(9):1749-1757.
• [16]Mee AS,Rowley JL.Rapid symptom relief in reflux oesophagitis:a comparison of lansoprazole and omeprazole[J].Aliment Pharmacol Ther,1996,10:757-763.
• [17]Adachi K,Hashimoto T,Hamamoto N.Symptom relief in patients with reflux esophagitis:Comparative study of omeprazole,lansoprazole,and rabeprazole[J].Journal of Gastroenterology and Hepatologyl,2003,18:1392-1398.
• [18]Dupas JL,Houcke P,Samoyeau R.Pantoprazole versus lansoprazole in French patients with reflux esophagitis[J].Gastroenterol Clin Biol,2001,25(3):245-250.
• [19]Castell DO,Kahrilas PJ,Richter JE.Esomeprazole(40mg)Compared With Lansoprazole(30mg)in the Treatment of Erosive Esophagitis[J].Am J Gastroenterol,2002,97(3):575-583.
• [20]Howden CW,Ballard ED,Robieson W.Evidence for Therapeutic Equivalence of Lansoprazole 30mg and Esomeprazole40mg in the Treatment of Erosive Oesophagitis[J].Clin Drug Invest,2002,22(2):99-109.